Extremely preterm birth is a medical crossroads where early survival can be followed by long-term neurodevelopmental challenges. In a new study published in Journal of Perinatology, researchers report that the pathway to identifying autism spectrum disorder (ASD) risk is not uniform among children born at the lowest gestational ages. The work focuses on what clinicians and health systems can infer when screening outcomes differ from what standard expectations would suggest.
Using data tied to routine ASD screening, the team examined patterns of “abnormal screening” in children with a history of extreme prematurity. The analysis highlights that screening performance—and the likelihood of an atypical result—may reflect a combination of biological vulnerability and the structure of follow-up care.
While ASD screening tools are designed to detect early behavioral signs, the study underscores that outcomes can be influenced by factors such as the child’s early medical course. Extremely preterm infants often experience complications that may affect brain development, including altered white-matter maturation and changes in early sensory processing. These mechanisms can contribute to delays or atypical trajectories that screening instruments attempt to capture.
Beyond biology, the results point to the importance of healthcare delivery. Differences in how families access developmental services, timing of assessments, and continuity of developmental surveillance can shape whether early signals are documented during the window when screening is most informative.
The findings are timely as perinatal medicine increasingly emphasizes “follow-up as prevention,” where monitoring is intended to trigger earlier evaluation, therapy, and support. The study suggests that abnormal screening should prompt systematic clinical review rather than be treated as a standalone label.
Importantly, the research does not claim that prematurity alone determines ASD outcomes. Instead, it reframes screening as a risk-detection process embedded in complex life-course factors. For clinicians, this means interpreting abnormal screening through a developmental lens—integrating perinatal history, current behavior, and the context of caregiver and service engagement.
For families, the study reinforces that early findings are best viewed as actionable prompts. When screening flags potential concerns, timely diagnostic assessment and early intervention can alter developmental trajectories, improving opportunities during a period of heightened neuroplasticity.
Subject of Research: Autism spectrum disorder screening in extremely preterm children
Article Title: Factors associated with abnormal screening for autism spectrum disorder among Extremely Preterm Children
Article References: Peralta-Carcelen, M., Hintz, S.R., Bann, C.M. et al. J Perinatol (2026). https://doi.org/10.1038/s41372-026-02693-y
Image Credits: AI Generated
DOI: 10.1038/s41372-026-02693-y
Keywords:
Tags: biological factors influencing autism risk in preterm infantsearly intervention strategies for autism in preterm populationsextremely preterm birth and autism screeninghealthcare delivery and access affecting autism risk assessmentimpact of early medical complications on autism screening outcomeslong-term neurodevelopmental outcomes in preterm infantsneurodevelopmental challenges in preterm childrenrole of follow-up care in autism detection forvariability in autism screening results among extremely preterm childrenwhite-matter development and sensory processing in preterm children
